Novo Nordisk | Passività Correnti

Current Liabilities Cambiamento Data
ANI Pharmaceuticals USD 145.48M 11.12M 2023-12
Aurora Cannabis CAD 242.3M 109.24M 2023-03
Bausch Health Companies USD 4.22B 257M 2023-09
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Canopy Growth CAD 196.25M 254.9M 2023-09
Catalent USD 1.04B 498M 2023-12
Corcept Therapeutics USD 104.5M 17.37M 2023-12
Eli Lilly USD 22B 3.08B 2023-09
GlaxoSmithKline GBP 22.39B 282M 2023-09
Merck USD 23.09B 300M 2023-09
Nektar Therapeutics USD 52.11M 1.42M 2023-09
Novo Nordisk DKK 172.55B 15.93B 2023-09
Pacira USD 97.38M 3.72M 2023-12
Perrigo USD 1.01B 48.5M 2023-09
Phibro Animal Health USD 172.36M 3.64M 2023-09
Prestige Brands USD 127.44M 2.27M 2023-12
Supernus Pharmaceuticals USD 290.2M 2.66M 2023-12
Zoetis USD 1.89B 281M 2023-12



Novo Nordisk Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.